Industry expresses concern over US FDA guideline on device changes needing new 510(k)s
This article was originally published in SRA
US medtech industry association AdvaMed warns that the number of pre-market notification applications that are submitted for device modifications could rise by 300-500% if a recent draft guideline by the Food and Drug Administration is implemented1. The association is concerned that the proposals in the draft document would result in the submission of more applications than the FDA can handle, resulting in unnecessary delays in the processing of submissions for new technologies and in patient access to modified devices.
You may also be interested in...
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-eight guidance documents have been posted on the tracker since its last update.